首页> 外文期刊>journal of biopharmaceutical statistics >Determining equivalence and the impact of sample size in anti-infective studies: a point to consider
【24h】

Determining equivalence and the impact of sample size in anti-infective studies: a point to consider

机译:Determining equivalence and the impact of sample size in anti-infective studies: a point to consider

获取原文
       

摘要

The problem of establishing the equivalence of an experimental treatment to a control with respect to a binary (#x201C;success#x201D; or #x201C;failure#x201D;) response variable may be solved using an approximate (1 -#x3B1;) 100 confidence interval for the difference in the response rates (i.e., success probabilities). If the goal is to show that the experimental treatment is not sufficiently worse than the control, then a decision rule based on the magnitude of one confidence limit can be used. A procedure suggested by the Food and Drug Administration allows the value to which the confidence limit is to be compared to depend on the data. The consequences of determining the sample size assuming that the aforementioned value is fixed are examined. The probability of declaring equivalence and exact sample sizes are also presented for the procedure.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号